Notably, according to the study from Lu et al., HNF1A overexpression could enhance sensitivity to gemcitabine by inhibiting ABCB1 transcription in pancreatic cancer [56], suggesting that the role of HNF1A in drug resistance is context dependent. The gene discussed is ABCB1; the disease is familial pancreatic carcinoma.